Online Courses

College Health - Module 1A: Introduction and Discussing Sexual Health with Patients

 

 

 

 

College Health
College Health Module 1A: Series Introduction and Discussing Sexual Health with Patients

This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how College Health providers can approach conversations about sexual health with patients, including trauma-informed care and consent.

 


 

This module is part of the College Health – Sexual Health Delivery series.  Modules include:
Module 1A - Introduction and Discussing Sexual Health with Patients
Module 2A - Creating an Environment of Equitable Care
Module 3A - STI Diagnosis and Testing (pending)
Module 4A - HIV Testing for Non-Traditional Settings (pending)
Module 5A - STI Treatment (pending)
Module 6A - STI/HIV Prevention (pending)

 


 

CONTINUING EDUCATION INFORMATION

PROGRAM DESCRIPTION: This enduring activity is designed for providers to develop skills in discussing sexual health with patients with focus on healthy relationships and treatment approaches specifically in college health, retail/urgent care and tribal health.

OBJECTIVES:
At the conclusion of the session, the participant should be able to:
1.     Describe the role of staff in providing sexual healthcare (college health)
2.     Describe the role of staff in STI management (college health)
3.     Describe effective strategies to build trust with patients when taking a sexual history
4.     Explain the importance of a trauma-informed approach in patient care
5.     Explain the “5Ps + 3” approach and its importance in the sexual history
6.     Describe one way that this educational activity will improve my contribution as a team member

FACULTY/                                                   CREDENTIALS:

Kevin L. Ard, MD, MPH; Director, Sexual Health Clinic, Massachusetts General Hospital,

Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Harvard Medical School

Philana Liang, PA-C, MPH, MSHS, SAFE; Physician Assistant/ Core Program Manager, St. Louis STD/HIV Prevention Training Center, Washington University St. Louis

Alison O. Marshall, PhD, FNP-C, RN; Faculty, Ratelle STD/HIV Prevention Training Center, Assistant Professor of the Practice, Boston College School of Nursing

Tamara Ooms, RN, MS, FNP-C; Clinical Faculty, Program Manager, California STD/HIV Prevention Training Center, University of California, San Francisco

Duran Rutledge, BA; Capacity Building Assistance Trainer/Technical Assistance Specialist, California STD/HIV Prevention Training Center, University of California, San Francisco

Katherine Yang, PharmD, MPH; Professor and CO-Vice Dean of Clinical Innovation and Entrepreneurship, University of California, San Francisco School of Pharmacy, University of California, Infectious Diseases Clinical Pharmacist, San Francisco Medical Center

Zoon Wangu, MD; Associate Professor of Pediatrics, UMass Chan Medical School; Attending Physician, Division of Pediatric Infectious Diseases & Immunology, UMass Memorial Children’s Medical Center; Clinical Faculty, Ratelle STD/HIV Prevention Training Center
 

CE ORIGINATION DATE:                       May 20, 2024
CE EXPIRATION DATE:                         May 20, 2026
HARDWARE/SOFTWARE:    Computer Hardware; Internet Connection; Browser                                                                      

MATERIALS:   None

TARGET AUDIENCE:  Physicians, Registered Nurses, Advanced  Practice Nurses, Certified Health Educators, Licensed Practical/Vocational Nurses, Medical Assistants, Other Health Educators, Pharmacists, Physician Assistants, Community Health Workers

PREREQUISITES:  Experience with patient care; otherwise, no prerequisites required.

FORMAT:  This activity is Web-based.

CONTACT INFORMATION:  National Network of STD Clinical Prevention Training Centers    Email:  info@nnptc.org  Phone: 303-602-3620

ACCREDITATION STATEMENTS: 

 

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention, National Network of STD Clinical Prevention Training Centers, and National Association of County and City Health Officials. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of (0.5) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Enduring Materials

The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for (0.5) AAPA Category 1 CME credits. Approval is valid until {May 20, 2026}.PAs should only claim credit commensurate with the extent of their participation.

CNE: The Centers for Disease Control and Prevention designates this activity for (0.5) nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive (0.05) CEUs in pharmacy education. The Universal Activity Number is JA4008229-9999-24-054-H08-P

After credit is claimed, an unofficial statement of credit is immediately available on CDC TRAIN. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer (0.1) CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to (0.5) total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are (0.5). Continuing Competency credits available are (0.5). CDC provider number 98614.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.   

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Ard and he wishes to disclose he receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate; and Dr. Wangu and she wishes to disclose she receives royalties from UpToDate, DynaMed, and Elsevier.

All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

If CEU only, Joint Provider: The Centers for Disease Control and Prevention, National Network of STD Clinical Prevention Training Centers (NNPTC) and National Association of County and City Health Officials (NACCHO) are jointly providing the CEUs for this activity. 
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WB4815(SC)A Introduction and Discussing Sexual Health with Patients Module 1 Series: College Health Module 1A please visit CDC TRAIN and search for the course in the Course Catalog using WB4815-052024A. Follow the steps below by 05/20/2026.

  • Register for and complete the course.
  • Pass the post-assessment at 80%.
  • Complete the evaluation.
  • Visit Your Learning to access your certificates and transcript.

FEES: No fees are charged for CDC’s CE activities.


ACKNOWLEDGMENTS


Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements:

  1. Suzanne M. Swierc, MPH, CHES (she/her), Director of Health Promotion & Advocacy, Ball State University, Muncie, IN 

  2. Melissa A. Habel, MPH (she/her), Strategic Partnerships and Planning Lead, Division of STD Prevention, Centers for Disease Control and Prevention

  3. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

College Health - Module 2A: Creating an Environment of Equitable Care

 

 

 

 

College Health
College Health Module 2A: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of LGBTQ+ youth, medical mistrust and equity gaps, creating a welcoming environment on campus, and unique aspects of STI care for college students including minors.

 


 

This module is part of the College Health – Sexual Health Delivery series.  Modules include:

Module 1A - Introduction and Discussing Sexual Health with Patients
Module 2A - Creating an Environment of Equitable Care

Module 3A - STI Diagnosis and Testing
Module 4A - HIV Testing for Non-Traditional Settings
Module 5A - STI Treatment
Module 6A - STI/HIV Prevention

 


 

 

CONTINUING EDUCATION INFORMATION

PROGRAM DESCRIPTION: This enduring activity is designed for providers to develop skills in discussing sexual health with patients with focus on healthy relationships and treatment approaches specifically in college health, retail/urgent care and tribal health.

OBJECTIVES:

At the conclusion of the session, the participant should be able to:

1.     Explain the concept of gender diversity (college health)
2.     Explain the needs of LGBTQ+ youth (college health)
3.     Discuss how health equity issues impact patient care (college health)
4.     Identify special circumstances surrounding STI testing and treatment of different age groups (college health)
5.     Describe one way that this educational activity will improve my contribution as a team member

  •  

FACULTY/                                                   CREDENTIALS:

Kevin L. Ard, MD, MPH; Director, Sexual Health Clinic, Massachusetts General Hospital,

Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Harvard Medical School

Philana Liang, PA-C, MPH, MSHS, SAFE; Physician Assistant/ Core Program Manager, St. Louis STD/HIV Prevention Training Center, Washington University St. Louis

Alison O. Marshall, PhD, FNP-C, RN; Faculty, Ratelle STD/HIV Prevention Training Center, Assistant Professor of the Practice, Boston College School of Nursing

Tamara Ooms, RN, MS, FNP-C; Clinical Faculty, Program Manager, California STD/HIV Prevention Training Center, University of California, San Francisco

Duran Rutledge, BA; Capacity Building Assistance Trainer/Technical Assistance Specialist, California STD/HIV Prevention Training Center, University of California, San Francisco

Katherine Yang, PharmD, MPH; Professor and CO-Vice Dean of Clinical Innovation and Entrepreneurship, University of California, San Francisco School of Pharmacy, University of California, Infectious Diseases Clinical Pharmacist, San Francisco Medical Center

Zoon Wangu, MD; Associate Professor of Pediatrics, UMass Chan Medical School; Attending Physician, Division of Pediatric Infectious Diseases & Immunology, UMass Memorial Children’s Medical Center; Clinical Faculty, Ratelle STD/HIV Prevention Training Center
 

CE ORIGINATION DATE:                       May 20, 2024
CE EXPIRATION DATE:                         May 20, 2026
HARDWARE/SOFTWARE:    Computer Hardware; Internet Connection; Browser                                                                      

MATERIALS:   None

TARGET AUDIENCE:  Physicians, Registered Nurses, Advanced  Practice Nurses, Certified Health Educators, Licensed Practical/Vocational Nurses, Medical Assistants, Other Health Educators, Pharmacists, Physician Assistants, Community Health Workers

PREREQUISITES:  Experience with patient care; otherwise, no prerequisites required.

FORMAT:  This activity is Web-based.

CONTACT INFORMATION:  National Network of STD Clinical Prevention Training Centers    Email:  info@nnptc.org  Phone: 303-602-3620

 ACCREDITATION STATEMENTS: 

 

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention, National Network of STD Clinical Prevention Training Centers, and National Association of County and City Health Officials. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of (0.5) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Enduring Materials

The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for (0.5) AAPA Category 1 CME credits. Approval is valid until {May 20, 2026}.PAs should only claim credit commensurate with the extent of their participation.

CNE: The Centers for Disease Control and Prevention designates this activity for (0.5) nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive (0.05) CEUs in pharmacy education. The Universal Activity Number is JA4008229-9999-24-054-H08-P

After credit is claimed, an unofficial statement of credit is immediately available on CDC TRAIN. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer (0.1) CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to (0.5) total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are (0.5). Continuing Competency credits available are (0.5). CDC provider number 98614.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Ard and he wishes to disclose he receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate; and Dr. Wangu and she wishes to disclose she receives royalties from UpToDate, DynaMed, and Elsevier.

All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

If CEU only, Joint Provider: The Centers for Disease Control and Prevention, National Network of STD Clinical Prevention Training Centers (NNPTC) and National Association of County and City Health Officials (NACCHO) are jointly providing the CEUs for this activity. 
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WB4817A Creating an Environment of Equitable Care Module 2 Series: College Health Module 2A please visit CDC TRAIN and search for the course in the Course Catalog using WB4817-052024A. Follow the steps below by 05/20/2026.

  • Register for and complete the course.
  • Pass the post-assessment at 80%.
  • Complete the evaluation.
  • Visit Your Learning to access your certificates and transcript.


FEES: No fees are charged for CDC’s CE activities.


ACKNOWLEDGMENTS


Content Lead:

Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements:

  1. Suzanne M. Swierc, MPH, CHES (she/her), Director of Health Promotion & Advocacy, Ball State University, Muncie, IN 

  2. Melissa A. Habel, MPH (she/her), Strategic Partnerships and Planning Lead, Division of STD Prevention, Centers for Disease Control and Prevention

  3. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

 

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

Congenital Syphilis: Prevention and Treatment

This course will cover screening for and treatment of syphilis in pregnant people, and prevention, evaluation, and treatment of congenital syphilis in infants using evidence-based best practices, case studies, and interactivity.

At the conclusion of the session, the participant should be able to:

  1. Describe how to diagnose and treat syphilis in a pregnant person.
  2. Describe how to diagnose and treat congenital syphilis in infants.
  3. Describe the importance of interprofessional collaboration in preventing, screening for, and treating congenital syphilis.

 

FACULTY/CREDENTIALS:

Josh Klein, BA, Program Coordinator, New York Presbyterian Hospital
Gowri Nagendra, MPH, Program Director, New York City STD Prevention Training Center
Natalie Neu, MD MPH, Medical Director, NYC STD Prevention Training Center; Associate Professor of Pediatrics/ Fellowship Director, Columbia University Medical Center Pediatric Infectious Disease
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center

ORIGINATION DATE: August 1, 2023
EXPIRATION DATE: August 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS:  None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals who provide clinical care for patients with STIs.
PREREQUISITES: The audience should provide clinical care for patients with STIs.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu 

ACCREDITATION STATEMENTS:

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center.  The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.

DISCLOSURE:

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE) 

CE instructions are provided after the completion of this course.

FEES: No fees are charged for CDC’s CE activities.

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Doxy-PEP: Expanding STI Prevention

 

This course discuses Doxy-PEP - a new tool in our STI prevention toolbox. We review evidence for Doxy-PEP, clinical questions, and Doxy-PEP implementation. 

This course is not accredited for continuing education. 

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Everyone Should Be Doing It: Taking a Sexual History

This course is a comprehensive overview of taking a sexual history. It covers rationale for why we should be taking a sexual history, how to set the stage for success, how to take an actual sexual history, and more. If you're someone who works with patients in a clinical setting, this course could be for you!

At the conclusion of the session, the participant should be able to:

1.     Describe three factors which contribute to obtaining an accurate sexual history. 
2.     Describe two approaches to taking a sexual history. 
3.     Describe the importance of interprofessional collaboration in taking sexual histories.

 FACULTY/CREDENTIALS:

Alwyn Cohall, MD, Principal Investigator, New York City STD Prevention Training Center; Professor of Public Health and Pediatrics, Columbia University Medical Center

Gowri Nagendra, MPH, Program Director, New York City STD Prevention Training Center

Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center

ORIGINATION DATE: August 1, 2023
EXPIRATION DATE: August 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS:  None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, other health professionals
PREREQUISITES: The audience should provide clinical care for patients and take sexual histories.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu 

ACCREDITATION STATEMENTS:

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center.  The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

DISCLOSURE:

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE)

CE instructions are provided after the completion of this course.

FEES: No fees are charged for CDC’s CE activities.

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

HIV Prevention Benefits Navigation

 

This course discusses available assistance programs for patients seeking HIV prevention who are uninsured, commercially insured, or who have Medicaid.

OBJECTIVES:

At the conclusion of the session, participants should be able to:

1. Describe HIV prevention assistance programs for uninsured patients.

2. Describe HIV prevention assistance programs for insured patients. 

3. Describe the importance of interprofessional collaboration in HIV prevention benefits navigation.

FACULTY/CREDENTIALS:

Caroline Carnevale, DNP, MPH, AAHIVS, Nurse Practitioner, Principal Investigator, New York Presbyterian Hospital, Comprehensive HIV Program; Core Faculty, New York City STD Prevention Training Center

Alexandra Filipkowski, BS, MPH candidate (’24), Intern, New York City STD Prevention Training Center

Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center

 

ORIGINATION DATE:                             November 1, 2023

EXPIRATION DATE:                               November 1, 2025

MATERIALS:                                          None

TARGET AUDIENCE:                             Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses,                                                                                                                      other health professionals

PREREQUISITES:                                 None

FORMAT:                                                This activity is Web-based/Web on Demand.

CONTACT INFORMATION:                    NYC STD Prevention Training Center, nycptc@cumc.columbia.edu 

 

ACCREDITATION STATEMENTS:

 


In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center.  The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

DISCLOSURE: 

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE) 

CE instructions are provided after the completion of this course.

FEES: No fees are charged for CDC’s CE activities.

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

 

Managing Syphilis: Providing Clinical Care in the Era of Bicillin L-A Shortages

 

This course discusses the current shortage of Penicillin G benzathine (Bicillin L-A). It covers the epidemiology of syphilis, how to screen for and stage syphilis, syphilis treatment guidelines, and guidelines for managing syphilis during this shortage. 

This short course is not accredited for continuing education. 

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

PrEP Guidelines: 2021 Update

This course will review CDC's 2021 updates to the PrEP guidelines. It covers PrEP screening and assessment, available PrEP options, prescribing PrEP, and ongoing PrEP management, including case studies and interactivity.

At the conclusion of the session, participants should be able to:

  1. Describe current CDC guidelines for PrEP.

  2. Describe clinical considerations for existing PrEP medications.
  3. Describe the importance of interprofessional collaboration in providing PrEP services.

 

FACULTY/CREDENTIALS:

Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center

ORIGINATION DATE: September 1, 2023
EXPIRATION DATE: September 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS:  None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, other health professionals

PREREQUISITES: The audience should provide clinical care for patients and discuss PrEP with patients.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu 

ACCREDITATION STATEMENTS:

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center.  The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

DISCLOSURE:

CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE) 

CE instructions are provided after the completion of this course.

FEES: No fees are charged for CDC’s CE activities.

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Retail Health/Urgent Care - Module 1 - Series Introduction and Discussing Sexual Health with Patients

 

 

 

 

Retail Health/Urgent Care
Retail Health/Urgent Care Module 1: Series Introduction and Discussing Sexual Health with Patients
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how Retail Health and Urgent Care providers can approach conversations about sexual health with patients, including trauma-informed care and consent.

 

Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements: 

  1. Nathan A. Bronstein, MPA, MsED, MSSP (he/him), Chief Operating Officer, Convenient Care Association

  2. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

 

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

Retail Health/Urgent Care - Module 2: Creating an Environment of Equitable Care

 

 

 

Retail Health/Urgent Care
Retail Health/Urgent Care Module 2: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of LGBTQ+ patients, medical mistrust and equity gaps, and unique aspects of STI care for minors.

 

Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements: 

  1. Nathan A. Bronstein, MPA, MsED, MSSP (he/him), Chief Operating Officer, Convenient Care Association

  2. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

 

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

Stress Management Series - Module 4: Cultivating Stress Hardiness

Title: Module 4: Cultivating Stress Hardiness

 

This module was a collaboration between the STI/HIV Prevention Training Center at Johns Hopkins and Lean in Systems & Solutions. It explores the concept of stress hardiness, underscoring the significance of control, commitment, and challenge in reframing stressful situations as avenues for both personal and professional development.

 

In this brief (10-15 minute)module, participants are invited to deepen their understanding of stress hardiness and learn to harness it to grow through healthcare-related stressors. Engage with this interactive, self-paced learning experience to uncover how stress hardiness can serve to prevent against the adverse effects of stress, including burnout.

 

"Hardiness, defined by Kobasa (1979) as a personality trait consisting of three fundamental characteristics (commitment, control, and challenge), is a protective factor against the negative effects of stress including burnout" (White et al., 2020).

 

Goal: Equip learners with the knowledge and skills to foster stress hardiness.

 

Learning Objectives:

 

-      Understand the foundational elements of stress hardiness: control, commitment, and challenge.

 

-      Explore strategies to cultivate stress hardiness.

 

Learn more about stress hardiness and how it can help protect you from the stress that frequently comes with engaging in providing healthcare.

 

Project/Content Lead:

 

Alexander Waitt, MS, MSEd, LPC (he/him)

Founder & Chief Executive Officer at Lean In Systems & Solutions

 

Audrey Collier, BS (she/her)

Project Manager, Lean In Systems & Solutions

 

Contributors:

 

Dr. Jamie Hanson, PhD (he/him)

Chief Scientist Officer at Lean In Systems & Solutions

Assistant Professor of Psychology, University of Pittsburgh

 

Dr. Alison DuBois, PhD, LPC (she/her)

Chief Wellness Officer, Lean In Systems & Solutions

President & CEO at The Mindful Mind, LLC

 

Nicole Luhanik, MS, LPC (she/her)

Clinical Director, Oasis Mental Health Services

 

Mercedes Robinson, MA, Ed.m (she/her)

Chief Executive Officer, Tequity In Action

Assistant Director of DEI, Ethical Culture Fieldston School

 

Salah Kanaan, MSc (he/him)

Chief Technology Officer at Lean In Systems & Solutions

 

Acknowledgements:

 

Barbara Wilgus, MSN, CRNP [She/Her/Hers]

Program Administrator, STD/HIV Prevention Training Center at Johns Hopkins; JHU Bayview Medical Center

 

References:

 

Kobasa S. C. (1979). Stressful life events, personality, and health: an inquiry into hardiness. Journal of Personality and Social sychology, 37(1), 1–11. https://doi.org/10.1037//0022-3514.37.1.1

 

Vagni, M., Maiorano, T., Giostra, V., Pajardi, D., & Bartone, P. (2022). Emergency Stress, Hardiness, Coping Strategies and Burnout in Health Care and Emergency Response Workers During the COVID-19 Pandemic. Frontiers in Psychology, 13, 918788. https://doi.org/10.3389/fpsyg.2022.918788

 

White, A., Zapata, I., Lenz, A., Ryznar, R., Nevins, N., Hoang, T. N., Franciose, R., Safaoui, M., Clegg, D., & LaPorta, A. J. (2020). Medical Students Immersed in a Hyper-Realistic Surgical Training Environment Leads to Improved Measures of Emotional Resiliency by Both Hardiness and Emotional Intelligence Evaluation. Frontiers in Psychology, 11, 569035. https://doi.org/10.3389/fpsyg.2020.569035

 

Disclosure:

 

The content experts involved in the creation of this module, including the collaboration between the STI/HIV Prevention Training Center at Johns Hopkins and Lean in Systems & Solutions, have declared that there are no financial relationships or conflicts of interest to disclose. This module is the product of our commitment to providing high-quality, unbiased education and training. Our team has worked diligently to ensure that the content is current, accurate, and developed independently of any commercial interests.

 

Tribal Health - Module 1: Series Introduction and Discussing Sexual Health with Patients

 

 

 

 

Tribal Health
Tribal Health Module 1: Series Introduction and Discussing Sexual Health with Patients
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how Tribal Health providers can approach conversations about sexual health with patients, including trauma-informed care, historical and intergenerational trauma, and a holistic and culturally-sensitive approach to health.

 

Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements: 

  1. Jessica Leston (Tsimshian), MPH (she/her), The Raven Collective

  2. Madalene Mandap, PharmD, BCPS, CPH, AAHIVE (she/her), Integrated Pharmacist, Southcentral Foundation, Anchorage, AK

  3. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

 

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

Tribal Health - Module 2: Creating an Environment of Equitable Care

 

 

 

 

Tribal Health
Tribal Health Module 2: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of two-spirit (2S) and LGBTQ+ patients, medical mistrust and equity gaps, and unique aspects of STI care for minors.

 

Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health


Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center

Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health

Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center

Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center

Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center

Acknowledgements: 

  1. Jessica Leston (Tsimshian), MPH (she/her), The Raven Collective

  2. Madalene Mandap, PharmD, BCPS, CPH, AAHIVE (she/her), Integrated Pharmacist, Southcentral Foundation, Anchorage, AK

  3. Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials

 

Disclosures:

Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.

 

We're Still Talking About Syphilis!

This course reviews syphilis screening, how to interpret results and stage disease, and syphilis treatment recommendations based on stage of disease. 

At the conclusion of the session, the participant should be able to:

  1. Describe the diagnostic considerations for syphilis.
  2. Describe how to treat syphilis. 
  3. Describe the importance of interprofessional collaboration in screening for and treating syphilis.

 

FACULTY/CREDENTIALS:

Alexandra Filipkowski, BS, MPH candidate (’24), Intern, New York City STD Prevention Training Center 
Natalie Neu, MD MPH, Medical Director, NYC STD Prevention Training Center; Associate Professor of Pediatrics/ Fellowship Director, Columbia University Medical Center Pediatric Infectious Disease
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center

ORIGINATION DATE: April 1, 2024
EXPIRATION DATE: April 1, 2026
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS:  None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals
PREREQUISITES: Intended for clinicians who provide clinical care for patients with STIs.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu 

ACCREDITATION STATEMENTS:

 

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD/HIV Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 0.75 nursing contact hours.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

DISCLOSURE:

In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.   

CDC, our planners and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Instructions for Obtaining Continuing Education (CE) 

Instructions for claiming CE are provided at the end of this course. 

FEES: No fees are charged for CDC’s CE activities.

Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.